may be technically difficult to image because of rapid clearance from the myocardium.
In the 1980s, the chemistry of new, cationic "mixedligand" Tc(III) complexes with the general formula [9' Tc"'LY2]1, where L is a tetradentate, dianionic ligand and Y is a monodentate tertiary phosphine, was extensively explored by Deutsch and coworkers6-9 in an attempt to develop an improved myocardial perfusion imaging agent. The synthesis and characterization, including single-crystal radiographic structural analysis, of this general class of nonreducible, cationic, mixedligand 99Tc(III) complexes have been reported.8 Their structure-activity studies10'11 showed that both the success of the synthesis and the biodistribution of the 99mTc(III) cationic complexes depend on the structure of the pendant groups attached to the L and Y ligands and on the nature of the four coordinating atoms of the L ligand. They also found that of all the complexes studied, the best biodistribution properties in terms of myocardial uptake and of blood, hepatobiliary, and renal clearance were observed when the L ligand is the Schiff base dianion 1,2-bis[dihydro-2,2,5,5-tetramethyl-3(2H)furanonato-4-methyleneimino]ethane and the Y ligand is tris(3-methoxy-1-propyl)phosphine. The structure of the technetium complex derived from these ligands (9'Tc-Q12) is given in Fig 1. The chemistry of Q12 is directly analogous to that of the complexes described previously. 8 The present study used a twostep batch preparation procedure for 99mTc-Q12. Recently, a kit formulation for this agent has been developed. 12 We hypothesized that in a canine model, '9mTc-Q12 myocardial distribution is related to actual myocardial blood flow during conditions of myocardial ischemia and pharmacological coronary artery vasodilation and that 99mTc-Q12 shows little or no myocardial redistribution as long as 4 hours after intravenous injection.
Methods

Animal Instrumentation
Animal studies conformed to the guidelines of the American Physiological Society and were approved by the Institutional Animal Care and Use Committee. Twenty-one male mongrel dogs weighing 21.6 to 26.4 kg were anesthetized with morphine sulfate (3 mg/kg) subcutaneously and 1% a-chloralose (70 mg/kg) intravenously. Anesthesia was supplemented as needed. The animals were intubated with a 10-mm-internaldiameter endotracheal tube and placed on a positive pressure ventilator (Harvard Apparatus Co), and ventilation was supplemented with 95% 02-5% CO2 to maintain arterial blood Po2 of more than 100 mm Hg. The chest was opened with a left lateral thoracotomy through the fourth intercostal space, and the heart was suspended in a pericardial cradle. An ultrasonic flow probe (Transonic Systems, Inc) was placed on the proximal portion of the left circumflex coronary artery. An hydraulic occluder was placed distal to the flow probe. A 22-gauge 2.5-cm plastic catheter was inserted into the distal portion of the left circumflex artery to monitor distal circumflex artery pressure. A 2.7-mm-diameter plastic catheter was placed in the left atrium for recording pressure and injecting radiolabeled microspheres. A 2.3-mm-diameter Goodale-Lubin catheter was inserted through a femoral artery and advanced into the ascending aorta for measurement of central aortic pressure and withdrawal of microsphere blood samples. A femoral vein was cannulated for administration of intravenous fluids and withdrawal of serial blood samples for measurement of 99mTc blood radioactivity levels. A balloon flotation catheter was inserted through the left subclavian vein and advanced into the pulmonary artery. The position of the flotation catheter in the pulmonary artery was verified by fluoroscopy. The The tris(3-methoxy-1-propyl)phosphine (TMPP) was kindly provided by Mallinckrodt Medical, Inc, with chemical identification and a certificate of analysis.
The synthesis of I'Tc-Q12 for this study followed the general two-step batch procedure developed by Deutsch et al.13 trans(1,2-bis[dihydro-2,2,5,5 -tetramethyl-3(2H)furanonato-4-methyleneimino]ethane)-bis(tris(3 -methoxy-1-propyl)phosphine) 99Tc(III), 9'Tc-Q12, was synthesized by reduction of 9'9Tc-pertechnetate (up to 120 mCi) with stannous chloride (10 to 30 jig) in argon-purged, basic 10% to 20% ethanol-saline solution containing the requisite Schiff base ligand (15 to 25 mg), thus forming an air-sensitive 9`"Tc(V) intermediate. Addition of TMPP hydrochloride (5.0 to 7.5 mg) solution further reduced the 9'Tc to the`9mTc(III) oxidation state and resulted in the formation of the 99`Tc-Q12 complex. Purification on a C-18 Sep-Pak Plus cartridge, elution with 80% ethanol in 0.9% sodium chloride, and then dilution with 0.9% sodium chloride yielded the final radiopharmaceutical. The I"'Tc-Q12 was then tested for radiochemical purity by high-performance liquid chromatography (HPLC) on a 150x4.1-mm PRP-1, 10-pm column (Hamilton Co) with a mobile phase of 90% methanol/10% 0.01 mol/L ammonium acetate (v/v) at a flow rate of 1.0 mL/min. Elution was monitored using a model 170 radioisotope detector (Beckman). For all preparations, the mean radiochemical purity was 99.5±+1.3%.
The identity of the 99`Tc-Q12 radiopharmaceutical was confirmed by Mallinckrodt Medical, Inc.14 The`mTc-Q12 radiopharmaceutical for structure confirmation was prepared using the method described above and a 99mTc-pertechnetate generator eluent that was spiked with a macroscopic amount of 99Tc-pertechnetate. After purification on a C-18 Sep-Pak cartridge, the green, carrier-added preparation was analyzed by HPLC using a dual-detector system. The UV trace (which monitors 99Tc) and the radiometric trace (which monitors 99mTc) exhibited peaks with identical chromatographic profiles, indicating that the two traces arose from the same chemical species. The major Tc-Q12 peak was collected off the HPLC, concentrated on a Waters C-18 Sep-Pak, and analyzed by fast atom bombardment mass spectroscopy (FAB-MS) at the University of Cincinnati. The positive-ion FAB mass spectra showed the parent peak at m/z=962, which is consistent with the Tc-Q12 cation (calculated average 962.1). Fragment ions corresponding to losses of the phosphine ligands and phosphine R groups, consistent with the structure given in Fig 1, were also observed. The FAB-MS fragmentation pattern observed for Q12 is identical to the fragmentation patterns of all other "0" complexes that have been analyzed. The FAB-MS data indicate the composition of the Q12 complex and are consistent with the structure depicted in Fig 1 . The heart was removed from the chest, and the instrumentation was removed. From the seven animals, a total of 315 myocardial samples were taken with 300 of the myocardial samples taken from varied locations in the left ventricle and 15 myocardial samples taken from the right ventricle. Approximately 90% of samples were transmural slices, with the remaining 10% of samples taken selectively from the subendocardium, subepicardium, or midmyocardium of the left ventricle. The samples were weighed and placed in 10% Formalin in counting vials. Within 4 hours after the animal was euthanized, each sample was counted for 9'Tc in a gamma well counter with a multichannel analyzer (model 1185, Tracor). The samples were stored for 1 week to allow 99mTc activity to decay to background levels and then recounted for measurement of radiolabeled microsphere activity.
Myocardial Kinetics Protocol
In the ischemic distribution of the left circumflex artery and in the transiently hyperemic distribution of the left anterior descending coronary artery, 9'Tc-Q12 activity was assessed over 4 hours for evidence of tracer redistribution. Fourteen dogs were instrumented, and baseline hemodynamic measurements were made as described previously. The left circumflex artery was occluded sufficiently so that reactive hyperemia was abolished in response to a proximal 10-second complete occlusion and subsequent release of a ligature on the artery. All animals had a zone of visible epicardial cyanosis distal to the coronary occluder before and/or during subsequent dipyridamole infusion. The animals were allowed to stabilize hemodynamically over 15 minutes. Dipyridamole (0.56 mg/kg) was infused over 4 minutes. Four minutes after dipyridamole infusion, 10 mCi of 9'9Tc-Q12 was injected into the right atrium.
Blood 99'Tc-Q12 disappearance was measured in 5 dogs by withdrawing 0.5 mL of blood into a heparinized 1-mL syringe every minute for 6 minutes, followed by measurement every 2 minutes for 20 minutes, every 5 minutes for 10 minutes, every 30 minutes for 90 minutes, and, finally, every 60 minutes for 2 hours. '9mTc-Q12 blood disappearance curves were constructed by previously reported methods. 16 After 99'Tc-Q12 injection, serial gamma camera images were obtained in the right anterior oblique projection as described above. The position of the animal remained constant throughout the entire experiment, as did the position of the gamma camera detector. Gamma camera images were obtained over 5 minutes at 5, 15, 30, 60, 120, 180, and 240 minutes after 99'Tc-Q12 injection and stored in a computer for later analysis.
Regional myocardial blood flow was measured by radiolabeled microspheres at four points in time after 9'Tc-Q12 injection. Three microsphere radionuclides (141Ce, 51Cr, and 103Ru) were randomly assigned for administration at three of the four times (30, 60, 120, and 240 minutes) after 9'9Tc-Q12 injection.
9'Tc myocardial counts were sampled by direct biopsy in the distribution of the patent left anterior descending coronary and partially occluded left circumflex arteries at 30, 60, 120, and 240 minutes after 99mTc-Q12 injection. The biopsy area was selected between the major coronary artery and a principal branch. A cyanotic appearance of the epicardium could be documented in the circumflex artery distribution selected for biopsy. A purse-string suture was placed around the biopsy site to ensure hemostasis. In eight animals, tissue samples were directly excised from the epicardium with a scalpel. In the last six animals studied, endocardial tissue was obtained by multiple direct biopsies of the beating heart with a Cope biopsy needle. Endocardial tissue samples generally weighed 10 to 30 mg and were placed in a labeled counting vial containing buffered Formalin.
Left and right atrial pressures, left circumflex coronary artery blood flow, distal circumflex artery pressure (in six dogs), systemic blood pressure, and cardiac rhythm were constantly monitored over 4 hours in all animals. Thermodilution cardiac output was determined in triplicate before each measurement of myocardial blood flow by microspheres. Hemodynamic changes, other than those attributable to dipyridamole infusion, were corrected with fluids or adjustment of the level of anesthesia.
On completion of the 4-hour protocol, the animal was euthanized with 100 mg/kg of pentobarbital IV. The heart was excised from the chest, instrumentation was removed, and each coronary artery was perfused for 10 B, Gamma camera images were viewed on the nuclear medicine computer screen and analyzed by a single observer (Fig  2) . On the 30-minute image from the kinetic protocol, a 5x5 -pixel region of interest was located centrally in the perfusion defect. A second 5x5-pixel region of interest was located centrally in the normally perfused anterior wall overlying the lung. A 5x5-pixel background region of interest was placed approximately 5 pixels outside the anterior wall. Background activity was subtracted from both myocardial regions, and the ratio of defect counts divided by normal zone counts was calculated. The procedure was repeated on the 5-, 15-, 60-, 120-, 180-, and 240-minute images for each animal studied by the kinetics protocol. Each image with associated regions of interest was photographed on radiographic film.
To determine the effect of postmortem intracoronary dye infusion on net myocardial radioactivity, two additional anesthetized, open chest dogs were instrumented as previously described, and 5.0 to 5.1 mCi of s'mTc-Q12 was injected intravenously. Constant hemodynamic conditions were maintained, and the animals were euthanized 31 and 37 minutes later, respectively. Each heart was placed into a plastic bag and inserted into a dose calibrator (model CRC-6A, Capintec, Inc), where 'mTc activity was counted. The heart was then removed from the dose calibrator, and the coronary arteries were infused with dye at 100 mm Hg pressure for 10 minutes as described above. The heart was then placed into a new plastic bag and reinserted into the dose calibrator for repeat counting. Measured radioactivity for the undyed heart was corrected for radioactive decay to the time of measurement of the same heart after introduction of dye. In the first animal, decaycorrected activity before dye infusion was 88.7 gCi compared with 88.9 gCi after dye infusion (0.2% difference). In the second animal, the decay-corrected predye 'mTc radioactivity was 90.8 gCi compared with 89.9 gCi after dye infusion (1.0% difference). It was concluded from the study of these two dogs that postmortem intracoronary infusion of acid magenta, acid orange, and methyl green stains at 100 mm Hg pressure has a negligible effect on myocardial retention of 'mTc-Q12.
Data Analysis
Data were expressed as the mean±1 SE. Hemodynamic data and radionuclide image ratios of counts in stenotic-tononstenotic regions were assessed for changes over time by a two-tailed, repeated-measures ANOVA, followed by the Scheffe F test. Linear regression analysis was used to relate microsphere coronary blood flow early after 99mTc-Q12 injection to 99-Tc myocardial counts in the seven individual animals.
To combine data from all seven animals, ' Table 2 summarizes the hemodynamic data from the myocardial kinetics protocol. Mean heart rate trended upward with dipyridamole infusion, but there was no statistically significant change in heart rate during the period of observation after dipyridamole infusion. Compared with baseline levels after partial circumflex artery occlusion, systolic and diastolic systemic blood pressures decreased significantly after dipyridamole infusion. Systolic and diastolic blood pressures then returned to postocclusion baseline levels at 60 minutes after 'smTc- circumflex territory was reduced to 0.28±0.05 mL. g`1 min1 at 30 minutes after dipyridamole infusion, increased significantly to 0.47±0.06 mL* g`1 min' at 120 minutes, and remained at 0.40±0.09 mL. g-1 * m -1 at 240 minutes. After intravenous dipyridamole administration, myocardial blood flow (Fig 6) at 30 minutes in the left anterior descending coronary artery distribution was 1.15±0.12 mL* g`1 in-1 but decreased to 0.81±0.08 mL* g`1 min' at 240 minutes (P<.05). Over 4 hours of measurement, myocardial blood flow in the distribution of the stenotic left circumflex artery increased, whereas myocardial blood flow in the distribution of the unobstructed left anterior descending coronary artery decreased.
Scintigraphy
The circumflex myocardial distribution over 4 hours, although the corresponding myocardial blood flow increased transiently at 120 minutes. 99Tc counts from the left ventricular subepicardial biopsies obtained by serial direct incisions in eight animals are also shown in Fig 8 (bottom) . Subepicardial 99mTc-Q12 myocardial activity remained constant from 30 to 240 minutes after Q12 injection in both coronary artery distributions.
The reduced endocardial biopsy but not epicardial biopsy 99mTc-Q12 activity in the distribution of the occluded left circumflex artery was evaluated further by analysis of larger postmortem myocardial samples. The relative distribution of~mTc-Q12 4 hours after its administration was evaluated in the subendocardium, midmyocardium, and subepicardium by dividing postmortem transmural sections from the left anterior descending and circumflex artery territories each into three slices. Fig 9 (top) shows that the distribution of 99mTc-Q12 in the left anterior descending region was uniform across the myocardial wall. 99mTc-Q12 activity in the distribution of the stenotic left circumflex artery was reduced in all myocardial layers relative to the anterior descending territory (P<.05), with a significantly greater reduction in circumflex endocardial than in epicardial activity (P<.05). This pattern of 99mTc-Q12 transmural distribution at 4 hours was similar to the transmural blood flow distribution pattern (Fig 9, bot After 99mTc-Q12 injection, its kinetics in the distribution of stenotic and nonstenotic coronary arteries were investigated over 4 hours after intravenous dipyridamole infusion. This model23 permits comparison of early myocardial tracer distribution under hyperemic conditions in the territory of the unobstructed left anterior descending coronary artery to late myocardial tracer distribution after dissipation of the coronary vasodilatory effects of dipyridamole. Simultaneously, the kinetics of 99mTc-Q12 were observed over 4 hours in the myocardial distribution of a partially occluded left circumflex artery. At approximately 30 minutes after dipyridamole infusion, reduced distal circumflex systolic blood pressure and reduced microsphere circumflex myocardial blood flow were documented in comparison to corresponding measurements that had returned to postocclusion baseline levels at 120 minutes after dipyridamole administration. Although the precise mechanism for this increase in circumflex myocardial blood flow between 30 and 120 minutes after 'mTc-Q12 injection cannot be proven, the observed changes in distal circumflex systolic pressure are consistent with a dipyridamole-induced myocardial steal beyond the circumflex occluder.
Although statistically significant and directionally opposite changes in regional myocardial blood flow occurred in normal and ischemic myocardial zones over 4 hours after 99mTc-Q12 injection, myocardial 99mTc-Q12 activity by direct myocardial biopsy and by scintigraphic ratio remained constant. These findings indicate that 99mTc-Q12 myocardial redistribution does not occur over 4 hours. The kinetic findings for 99mTc-Q12 are similar to the previously reported kinetics for 99"Tc-sestamibi. 23, 31 Those studies document minimal myocardial washout dial blood flow from microsphere quantitation is exemand redistribution of sestamibi such that the degree of washout is not likely to be of clinical importance. 23, 33 The myocardial kinetics of 991Tc-Q12 differ from those of 2OlTl,34-36 which show clinically important myocardial redistribution, and from those of 9'9Tc-teboroxime, which show evidence of differential myocardial washout from ischemic and nonischemic areas. [37] [38] [39] Potential limitations of the present study include the blind nature of the serial endocardial biopsies for assessment of 9'9Tc-Q12 activity over 4 hours. Because the endocardial surface is not visualized during the Cope needle biopsies of the beating heart, the possibility exists that not all endocardial muscle samples may be accurately located in the central distribution of either the left anterior descending or left circumflex coronary artery but could be located in an area with overlapping flow from both arteries. Other investigators have used alternative methods for counting regional myocardial tracer activity, including miniature cadmium telluride radiation detectors that can be implanted on the endocardial and epicardial walls.23 '31,34 The latter approach ensures a relatively constant location of serial radioactivity detection but is less direct (ie, samples a transmural section of tissue that may have a heterogeneous flow and 'Tc distribution, as illustrated in Fig 9) compared with the present method of direct Cope biopsy needle sampling followed by tissue counting in a well counter. Location of the Cope needle endocardial biopsy sites was verified at postmortem examination of the heart in the present study. In addition, in this study, the lack of change in 99mTc-Q12 activity over time was verified by two other independent methods -serial incisional epicardial biopsies under direct visualization in eight dogs and external gamma camera quantitation of a ratio of defect zone to nondefect zone activity in all animals.
A second consideration is the limited elevation of coronary blood flow at approximately 30 minutes after dipyridamole administration. Hintze and Vatner40 have shown that coronary cross-sectional area increased and diastolic coronary vascular resistance decreased significantly within 5 minutes after dipyridamole infusion. However, by 30 minutes after dipyridamole administration, coronary cross-sectional area and diastolic vascular resistance had largely returned to baseline levels. Afonso41 produced marked increases in coronary blood flow by administering 5 mg dipyridamole into the right atrium in mongrel dogs. By 15 to 20 minutes later, coronary blood flow had returned nearly to baseline levels. In the present study, in the myocardial perfusion group, all dogs had microsphere measurements of myocardial blood flow within 4 minutes after dipyridamole infusion, and myocardial blood flows of c8 mL* g`min`were documented.
In the 14 animals studied by the 4-hour myocardial kinetics protocol, maximal myocardial blood flow by microsphere techniques at 30 minutes after dipyridamole infusion was 1.85 mL. g`. minm. If earlier samples of 'Tc-Q12 tissue activity and corresponding microsphere blood flow measurements had been taken at 10 to 15 minutes after dipyridamole infusion, a larger change in blood flow over 4 hours might have been recorded. However, the kinetics protocol was designed before the blood clearance of 9'Tc-Q12 was known, and there was some concern that quantitation of myocardial samples taken very early after 99mTTc-Q12 injection might have been confounded by delayed tracer uptake. Regardless of the limited residual effect of dipyridamole infusion on myocardial blood flow at 30 minutes after 9'9Tc-Q12 injection, microsphere myocardial blood flow in the left circumflex coronary artery distribution was transiently increasing at 120 minutes, whereas myocardial flow in the left anterior descending distribution was decreasing, and the corresponding blood flow ratio increased from 0.24 to 0.49. The corresponding ratio of defect zone to nondefect zone 9'9Tc-Q12 activity by external imaging remained constant from 30 to 240 minutes. Thus, 99'Tc-Q12 activity was unchanged over 4 hours, whereas the ratio of relative circumflex to anterior descending myocardial blood flow doubled.
Caution is required in attempts to extrapolate from the results of these canine studies to the likely perfusion and kinetic properties of 9'Tc-Q12 in humans. Nevertheless, Rossetti and associates30 reported that 9'Tc-Q12 showed no evidence of myocardial washout over 5 hours in five healthy volunteers.
9'9Tc-Q12 holds clinical promise as a myocardial perfusion imaging agent. The present investigation in dogs suggests that 9'Tc-Q12 activity in the myocardium is directly related to actual myocardial blood flow over a clinically relevant range, that the tracer is rapidly cleared from the blood, and that, once extracted, 99mTc-Q12 remains relatively fixed in the myocardium over 4 hours. Further evaluation of 'Tc-Q12 for myocardial imaging appears to be justified.
